Skip to contentE
Envoy Medical, Inc.
E
COCHEnvoy Medical, Inc. Q2 2025 · 10-Q
Revenue$78.00K$78.00K+14.7% vs Q2 2024 Net Income-$5.69M-$5.69MN/M vs Q2 2024 EPS Diluted-$0.32-$0.32N/M vs Q2 2024 Operating Income-$5,070,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Envoy Medical, Inc. · CIK 1840877 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$4,461,000N/M Margins · derivedOperating margin-6500.0%+635.3 pt vs Q2 2024
Net margin-7294.9%−1490.5 pt vs Q2 2024
ended Jun 30, 2025 · filed Jul 31, 2025 · 31 d after period end